Mergers & Acquisitions

Mergers & Acquisitions Law360 provides breaking news and analysis on high-impact mergers and acquisitions and the attorneys involved. Coverage includes major deals, related litigation and enforcement actions, and policy developments that affect corporate dealmaking.



Sign up for a 7-day FREE trial today!



Latest News in Mergers & Acquisitions

  • November 17, 2025

    Chancery Mulls Receiver For Foundering Gaming Chat Co.

    Saying the court stands at "the outer boundaries" of precedent, a Delaware vice chancellor on Monday declined for now to appoint a receiver for voided online gaming chat venture TeamSpeak and ordered targeted discovery regarding the standing of a stockholder who sued the company's directors and others for alleged breaches of fiduciary duty.

  • November 17, 2025

    UConn Health Poised To Buy Hospital In $35M Ch. 11 Deal

    Bankrupt for-profit hospital operator Prospect Medical Holdings Inc. on Monday sought approval for the $35 million sale of Waterbury Hospital in Connecticut to two UConn Health units under a stalking horse bid package filed in early November.

  • November 17, 2025

    DOJ Defends HPE Merger Deal As 'Prudent Compromise'

    The Justice Department told a California federal judge to pay no heed to the "politicians and advocacy groups" opposing the controversial settlement clearing Hewlett Packard Enterprise's $14 billion purchase of Juniper Networks, arguing their concerns about improper lobbying influence are outside the scope of the court's review.

  • November 17, 2025

    TerraForm Stockholders Settle Suit Over Brookfield Merger

    Brookfield Asset Management Inc. and TerraForm Power Inc. stockholders reported a tentative, undisclosed deal on Monday to end their nearly four-year Delaware Chancery Court battle over Brookfield's alleged "exploitation" of TerraForm's minority stockholders in a deal dating to 2020.

  • November 17, 2025

    Cravath, Goodwin Advise On J&J's $3B Cancer Drug Play

    Cravath-advised Johnson & Johnson said Monday it has agreed to pay $3.05 billion in cash for Goodwin-led Halda Therapeutics, a biotech developing a clinical-stage therapy for prostate cancer.

See more Mergers & Acquisitions news

Mergers & Acquisitions

Areas of Coverage

  • TRANSACTIONS
  • Mergers and acquisitions valued at $100MM or more
  • Company spinoffs and splitups
  • Transactions involving stakes of $100MM or more
  • Hostile takeovers and leveraged buyouts
  • Poison pill implementation
  • Bankruptcy selloffs
  • AGENCIES
  • Financial Industry Regulatory Authority
  • Federal Trade Commission
  • U.S. Department of Justice
  • POLICY & REGULATION
  • Dodd-Frank Act
  • International banking legislation and regulation
  • ENFORCEMENT
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • LITIGATION
  • Antitrust suits
  • Bankruptcy proceedings
  • Shareholder disputes
  • Corporate governance fights
  • Proxy battles and hostile takeover suits
  • Poison pill challenges
  • PROFILES
  • Personnel moves
  • Profiles of mergers and acquisitions practices

Readership

  • Mergers and acquisitions lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals